Revance Therapeutics | 债务利息支出



Interest Expense On Debt 更改 日
AbbVie USD 610M 19M 2024-12
ALKERMES USD 0 4.65M 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
J&J USD 128M 9M 2025-03
Merck USD 313M 15M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
P&G USD 217M 23M 2025-03
Pacira USD 3.71M 967K 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12



Revance Therapeutics 债务利息支出 - 当前值，历史数据，预测，统计，图表和经济日历 - Jul 2025.